Intratumoral levels of estrogens in breast cancer

Journal of Steroid Biochemistry and Molecular Biology

Volumn 69, Issue 1-6, 1999, Pages 293-297

  Blankenstein, M A ^a   Van De Ven, J ^a   Maitimu Smeele, I ^a   Donker, G H ^a   De Jong, P Chr ^a   Daroszewski, J ^b   Szymczak, J ^b   Milewicz, A ^b   Thijssen, J H H ^a  

^a UNIVERSITY MEDICAL CENTER UTRECHT   (Netherlands)

^b MEDICAL UNIVERSITY OF LUBLIN   (Poland)

Author keywords

[No Author keywords available]

Indexed keywords

ANDROGEN; AROMATASE INHIBITOR; ESTRADIOL; ESTROGEN; HORMONE PRECURSOR; VOROZOLE;

BREAST CANCER; CONFERENCE PAPER; CONTROLLED STUDY; DRUG EFFECT; ENZYME ACTIVITY; ESTROGEN SYNTHESIS; FEMALE; HUMAN; HUMAN TISSUE; MASTECTOMY; ORAL DRUG ADMINISTRATION; POSTMENOPAUSE;

BREAST NEOPLASMS; ESTROGENS; HUMANS;

EID: 0033011088     PISSN: 09600760     EISSN: None     Source Type: Journal    
DOI: 10.1016/S0960-0760(99)00048-5     Document Type: Conference Paper

References (18)

1. Thijssen J.H.H., Blankenstein M.A., Donker G.H., Daroszewski J. Endogenous steroid hormones and local aromatase activity in the breast. Journal of Steroid Biochemistry and Molecular Biology. 39:1991;799-804.
2. Van der Wall E., Donker T.H., de Frankrijker E., Nortier H.W.R., Thijssen J.H.H., Blankenstein M.A. Inhibition of the in vivo conversion of androstenedione to estrone by the aromatase inhibitor vorozole in healthy postmenopausal women. Cancer Research. 53:1993;4563-4566.
3. De Jong P.C., van de Ven J., Nortier H.W.R., Maitimu-Smeele I., Donker T.H., Thijssen J.H.H., Slee P.H.T.J., Blankenstein M.A. Inhibition of breast cancer tissue aromatase by the third-generation aromatase inhibitor vorozole. Cancer Research. 57:1997;2109-2111.
4. Blankenstein M.A., Maitimu-Smeele I., Donker G.H., Daroszewski J., Milewicz A., Thijssen J.H.H. On the significance of in situ production of oestrogens in human breast cancer tissue. Journal of Steroid Biochemistry and Molecular Biology. 41:1992;891-896.
5. Blankenstein M.A., Maitimu-Smeele I., Donker G.H., Daroszewski J., Milewicz A., Thijssen J.H.H. Tissue androgens and endocrine autonomy of breast cancer. Journal of Steroid Biochemistry and Molecular Biology. 43:1992;167-171.
6. Reed M.J., Aherne G.W., Ghilchik M.W., Patel S., Chakraborty J. Concentrations of oestrone and 4-hydroxyoestrone in malignant and normal; breast tissues. International Journal of Cancer. 49:1991;562-565.
7. Edermy M., Goussard J., Dehennin L., Scholler R., Reiffsteck J., Drosdoswsky M.A. Endogenpous oestradiol 17β concentration in breast tumours determined by mass fragmentography and by radioimmunoassay: relationship to receptor content. European Journal of Cancer. 17:1981;115-120.
8. Van Landeghem A.A.J., Poortman J., Nabuurs M., Thijssen J.H.H. Endogenous concentration and subcellular distribution of estrogens in normal and malignant human breast tissue. Cancer Research. 45:1985;2900-2906.
9. Blankenstein M.A., Daroszewski J., Szymczak J., Milewicz A., Thijssen J.H.H. The importance of extraglandular oestrogen biosynthesis in their maintenance of breast cancer tissue oestradiol levels. Genazzani A.R., Petraglia F. Hormones in Gynecological Endocrinology. Proc. III International Congress of Gynecological Endocrinology. 1992;513-521 Parthenon Press, Carnforth, UK.
10. Miller W.R., O'Neill J. The importance of local synthesis of estrogen within the breast. Steroids. 50:1987;537-548.
11. Thijssen J.H.H., Blankenstein M.A. Endogenous oestrogens and androgens in normal and malignant endometrial and mammary tissues. European Journal of Cancer and Clinical Oncology. 25:1989;1953-1959.
12. James V.H.T., Reed M.J., Lai L.C., Ghilchik M.W., Tait G.H., Newton C.J., Coldham N.G. Regulation of oestrogen concentrations in human breast tissues. Annals of the New York Academy of Sciences. 595:1990;227-235.
13. Larner J.M., Shackleton C.H.L., Roitman E., Schwartz P.E., Hochberg R.B. Measurement of estradiol-17-fatty acid esters in human tissues. Journal of Clinical Endocrinology and Metabolism. 75:1992;195-200.
14. Frisch R.E., Snow R.C., Johnson L.A., Gerard B., Barbieri R., Rosen B. Magnetic resonance imaging of overall and regional body fat, estrogen metabolism, and ovulation of athletes compared to controls. Journal of Clinical Endocrinology and Metabolism. 77:1993;471-477.
15. Szymczak J., Milewicz A., Thijssen J.H.H., Blankenstein M.A., Daroszewski J. Concentrations of sex steroids in adipose tissue after menopause. Steroids. 63:1998;319-321.
16. Wouters W., De Coster R., van Dun J., Krekels M.D.W.G., Dillen A., Raeymakers F., Freyne E., van Gelder I., Sanz G., Venet M., Janssens M. Comparative effects of the aromatase inhibitor R76713 and of its enantiomers R83839 and R83842 on steroid biosynthesis in vitro and in vivo. Journal of Steroid Biochemistry and Molecular Biology. 37:1990;1049-1054.
17. Yue W., Brodie A.M.H. Mechanisms of the actions of aromatase inhibitors 4-hydroxtyandrostenedione, fadrozole and aminoglutethimide on aromatase in JEG-3 cell culture. Journal of Steroid Biochemistry and Molecular Biology. 63:1997;317-328.
18. Harada N., Hatano O. Inhibitors of aromatase prevent degradation on the enzyme in human tumour cells. British Journal of Cancer. 77:1998;567-572.